Pat Cogan
About Pat Cogan
Pat Cogan serves as the Global Head of Financial Planning & Analysis at Amylyx Pharmaceuticals, bringing extensive experience from previous roles at various companies including Teradyne and Sarepta Therapeutics.
Current Role at Amylyx Pharmaceuticals
Pat Cogan serves as the Global Head of Financial Planning & Analysis at Amylyx Pharmaceuticals. In this role, he is responsible for overseeing financial strategies and ensuring effective financial management across the organization. He has been with Amylyx since 2021, contributing to the company's financial planning and analysis efforts.
Previous Experience at Teradyne
Before joining Amylyx Pharmaceuticals, Pat Cogan worked at Teradyne as Division Controller from 1990 to 2007. During his 17-year tenure, he managed financial operations and provided insights that supported the division's strategic goals.
Professional Background in Financial Consulting
Pat Cogan has held various consulting roles, including a position as Senior Consultant at FORUM Pharmaceuticals for 10 months in 2014. He also worked as a Senior Financial Planning and Analysis Consultant at Rapid Micro Biosystems for 4 months in 2015, where he applied his expertise in financial analysis.
Education and Qualifications
Pat Cogan earned a Bachelor of Business Administration (BBA) in Accounting from the University of Notre Dame, where he studied from 1982 to 1986. His educational background provides a strong foundation for his extensive career in finance.
Recognition and Achievements
Throughout his career, Pat Cogan has been recognized as a TopTalent in Finance, highlighting his exceptional skills and contributions to the field. He has also designed strategic decision support reporting systems that enhance financial performance analysis, showcasing his ability to drive financial insights.